Biostage Inc. (BSTG) Stock Price & Overview

NASDAQ:BSTG

Current stock price

0.23
-0.07 (-23.33%)
At close:
0.25
+0.02 (+8.7%)
After Hours:

The current stock price of BSTG is 0.23 null. Today BSTG is down by -23.33%. In the past month the price decreased by -25.32%. In the past year, price decreased by -75.53%.

BSTG Key Statistics

52-Week Range0.2 - 1.42
Current BSTG stock price positioned within its 52-week range.
1-Month Range0.2 - 0.36
Current BSTG stock price positioned within its 1-month range.
Market Cap
8.977M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.61
Dividend Yield
N/A

BSTG Stock Performance

Today
-23.33%
1 Week
-25.81%
1 Month
-25.32%
3 Months
-46.51%
Longer-term
6 Months -28.13%
1 Year -75.53%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

BSTG Stock Chart

Biostage Inc. / BSTG Daily stock chart

BSTG Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to BSTG. When comparing the yearly performance of all stocks, BSTG is a bad performer in the overall market: 96.23% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BSTG Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to BSTG. BSTG has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BSTG Earnings

Next Earnings DateApr 11, 2022
Last Earnings DateN/A

BSTG Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

BSTG Financial Highlights

Over the last trailing twelve months BSTG reported a non-GAAP Earnings per Share(EPS) of -0.614. The EPS increased by 7.92% compared to the year before.


Income Statements
Revenue(TTM)54.00K
Net Income(TTM)-13.84M
Industry RankSector Rank
PM (TTM) -25627.78%
ROA -297.23%
ROE -1081.17%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%44.39%
Sales Q2Q%-100%
EPS 1Y (TTM)7.92%
Revenue 1Y (TTM)-26.03%

BSTG Ownership

Ownership
Inst Owners0.03%
Shares39.03M
Float37.47M
Ins Owners6.21%
Short Float %N/A
Short RatioN/A

About BSTG

Company Profile

Biostage, Inc. is a biotechnology company. It is engaged in developing bioengineered organ implants based on the company's new Cellframe (TM) technology to treat life-threatening conditions of the esophagus, trachea or bronchus. Biostage Inc., formerly known as Harvard Apparatus Regenerative Technology Inc., is based in HOLLISTON, Mass.

Company Info

Biostage Inc.

84 October Hill Road Suite 11

Holliston MA 01746

CEO: James McGorry

Phone: 774-233-7300

Biostage Inc. / BSTG FAQ

What does BSTG do?

Biostage, Inc. is a biotechnology company. It is engaged in developing bioengineered organ implants based on the company's new Cellframe (TM) technology to treat life-threatening conditions of the esophagus, trachea or bronchus. Biostage Inc., formerly known as Harvard Apparatus Regenerative Technology Inc., is based in HOLLISTON, Mass.


Can you provide the latest stock price for Biostage Inc.?

The current stock price of BSTG is 0.23 null. The price decreased by -23.33% in the last trading session.


Does Biostage Inc. pay dividends?

BSTG does not pay a dividend.


What is the ChartMill technical and fundamental rating of BSTG stock?

BSTG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


How is the valuation of Biostage Inc. (BSTG) based on its PE ratio?

Biostage Inc. (BSTG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.61).


Can you provide the market cap for Biostage Inc.?

Biostage Inc. (BSTG) has a market capitalization of 8.98M null. This makes BSTG a Nano Cap stock.